A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.

被引：0
|
作者：
Neuhaus, P
Oettle, H
Post, S
Gellert, K
Ridwelski, K
Schramm, H
Zülke, C
Fahlke, G
Langrehr, J
Riess, H
机构：
[1] Stadt Klinikum Magdeburg, Berlin, Germany
[2] Waldklinikum, Gera, Germany
[3] Otto Von Guericke Univ, Magdeburg, Germany
[4] Virchow Klinikum, Charite Campus, Berlin, Germany
[5] Univ Klinikum Regensburg, Mannheim, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1092S / 1092S
页数：1
相关论文
共 50 条
  • [31] Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial
    Scheithauer, Werner
    Ramanathan, Ramesh K.
    Moore, Malcolm
    Macarulla, Teresa
    Goldstein, David
    Hammel, Pascal
    Kunzmann, Volker
    Liu, Helen
    McGovern, Desmond
    Romano, Alfredo
    Von Hoff, Daniel D.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (03) : 469 - +
  • [32] Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer
    Boku, N.
    Uesaka, K.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S77 - S77
  • [33] CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
    Sinn, Marianne
    Bahra, Marcus
    Liersch, Torsten
    Gellert, Klaus
    Messmann, Helmut
    Bechstein, Wolf
    Waldschmidt, Dirk
    Jacobasch, Lutz
    Wilhelm, Martin
    Rau, Bettina M.
    Gruetzmann, Robert
    Weinmann, Arndt
    Maschmeyer, Georg
    Pelzer, Uwe
    Stieler, Jens M.
    Striefler, Jana K.
    Ghadimi, Michael
    Bischoff, Sven
    Doerken, Bernd
    Oettle, Helmut
    Riess, Hanno
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3330 - +
  • [34] A PHASE II TRIAL OF THE COMBINATION OF GEMCITABINE AND CARBOPLATIN AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER. (KENBYO 0601)
    Muraoka, Masashi
    Akamine, Shinji
    Tsuchiya, Tomoshi
    Morino, Shigeyuki
    Kamohara, Ryotaro
    Mochinaga, Koji
    Shimoyama, Koichiro
    Sengyoku, Hideyori
    Obata, Tomohiro
    Mizoguchi, Satoshi
    Ikuta, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S581 - S581
  • [35] Effect of time to initiation of adjuvant chemotherapy on survival in resected pancreatic cancer.
    Mirkin, Katelin Anne
    Hollenbeak, Christopher S.
    Wong, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [36] A phase III trial of virulizin plus gemcitabine vs. gemcitabine alone in advanced pancreatic cancer: Results of subgroup analysis.
    Wright, J. A.
    Osterlee, J.
    Fekete, S.
    Lee, Y.
    Young, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 206S - 206S
  • [37] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Schaberl-Moser, R.
    Greil, R.
    Thoedtmann, R.
    Tschmelitsch, J.
    Jagoditsch, M.
    Steger, G. G.
    Jakesz, R.
    Herbst, F.
    Hofbauer, F.
    Rabl, H.
    Wohlmuth, P.
    Gnant, M.
    Thaler, J.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1021 - 1027
  • [38] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    W Schippinger
    H Samonigg
    R Schaberl-Moser
    R Greil
    R Thödtmann
    J Tschmelitsch
    M Jagoditsch
    G G Steger
    R Jakesz
    F Herbst
    F Hofbauer
    H Rabl
    P Wohlmuth
    M Gnant
    J Thaler
    British Journal of Cancer, 2007, 97 : 1021 - 1027
  • [39] Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer
    Maisonneuve, Patrick
    Lowenfels, Albert B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (23): : 2581 - 2581
  • [40] Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
    Ponweera, Arachchige
    Robinson, Matthew
    Jackson, Richard
    Halloran, Chris
    Palmer, Dan
    Hackert, Thilo
    Costello, Eithne
    Greenhalf, Bill
    Buechler, Markus
    Neoptolemos, John
    Ghaneh, Paula
    BRITISH JOURNAL OF SURGERY, 2022, 109
12345